fda approvals in hcc and gastric cancer, odac panel splits on adjuvant rcc treatment, and more
Published 6 years ago • 177 plays • Length 8:16
Download video MP4
Download video MP3
Similar videos
-
12:19
fda approvals in hcc, rcc, and cll, and odac recommendations
-
8:07
fda approval in lung cancer, priority reviews in hcc and nhl, and an odac recommendation
-
9:38
fda approval in rcc, odac meetings scheduled in tgct and aml, and more
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
11:32
fda approvals in breast cancer and nsclc, nda accepted in hcc, and more
-
8:10
fda approval for cll, odac vote in lung cancer, european regulatory advances, and more
-
7:19
fda approval in hcc, priority reviews in tnbc and ovarian cancer, snda in itp, and more
-
7:07
fda approval in crc, priority review in hcc, encouraging data in myeloma trial, and more
-
5:39
hcc: criteria for resection and adjuvant therapy
-
7:39
fda approvals in all, ovarian cancer, priority review in ctcl, and snda submitted in rcc
-
8:12
fda approvals in hcc, sclc, and nsclc, priority review in rare blood cancer, and more
-
9:37
fda approvals in nhl and cinv, priority reviews in melanoma and breast cancer, and more
-
5:31
odac vote against agent in bladder cancer and european regulatory updates in rcc and more
-
11:31
adjuvant and combination therapies for hcc
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
1:27
dr. abou-alfa discusses the storm trial in hcc
-
8:45
fda approvals in gvhd, crc, and aml, a priority review in mcl, and more
-
0:59
dr. weber on the fda approval for fixed-dose of nivolumab
-
5:31
fda d.i.s.c.o.: fda approval of cabozantinib for hepatocellular carcinoma
Clip.africa.com - Privacy-policy